Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · IEX Real-Time Price · USD

14.98

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

15.07

+0.09 (0.60%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

DAWN Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	84.07	75.54	61.29	29.16	4.68	1.01
Research & Development	142.9	130.52	85.62	43.58	9.1	13.9
Operating Expenses	226.98	206.06	146.91	72.74	13.78	14.91
Operating Income	-226.98	-206.06	-146.91	-72.74	-13.78	-14.91
Interest Expense / Income	0	0	0	0	0.03	2.08
Other Expense / Income	-18.04	-17.15	-4.73	97.9	26.7	0
Pretax Income	-208.94	-188.92	-142.18	-170.64	-40.51	-16.98
Net Income	-208.94	-188.92	-142.18	-170.64	-40.51	-16.98
Preferred Dividends	0	0	0	0	0	-4.35
Net Income Common	-208.94	-188.92	-142.18	-170.64	-40.51	-12.63
Shares Outstanding (Basic)	87	80	65	37	6	6
Shares Outstanding (Diluted)	87	80	65	37	6	6
Shares Change	20.43%	21.85%	77.13%	568.42%	-6.67%	-
EPS (Basic)	-2.51	-2.37	-2.17	-4.62	-7.33	-2.13
EPS (Diluted)	-2.51	-2.37	-2.17	-4.62	-7.33	-2.13
Free Cash Flow	-170.8	-147.08	-109.9	-48.54	-13.58	-4.52
Free Cash Flow Per Share	-1.97	-1.84	-1.68	-1.31	-2.46	-0.76
EBITDA	-208.53	-188.53	-141.65	-170.44	-40.32	-14.91
Depreciation & Amortization	0.41	0.38	0.53	0.2	0.16	0
EBIT	-208.94	-188.92	-142.18	-170.64	-40.48	-14.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).